2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guide...
Saved in:
Published in | Journal of cardiac failure Vol. 28; no. 5; p. e1 |
---|---|
Format | Journal Article |
Language | English |
Published |
United States
01.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.
A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.
Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses. |
---|---|
AbstractList | The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.
A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.
Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses. The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.AIMThe "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.METHODSA comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.STRUCTUREHeart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35378257$$D View this record in MEDLINE/PubMed |
BookMark | eNpNT0tLxDAYDLLiPvQvLDl6aTdJkyZ7klLsVljxoJ5LmnzRLn2Ztgf__VZcQRiYOcyDWaNF27WA0JaSkBIa706h0d46XdUhI4yFZAYlV2hFRcQCxSlf_NNLtB6GEyFEcSJv0DISkVRMyBV6-EnjJE92SZru8uw1wYepslBXLWDXeTx-An7Wrf6ABtoRdw7noP2Is3l68nCLrp2uB7i78Aa9Z49vaR4cXw5PaXIMekbpGBjFnYyMpAqE1CyWnMclJ9YJa0pihaKcgxFQggEGe6MVUFGqPWinrCY22qD7397ed18TDGPRVIOButYtdNNQsJhLRplU-9m6vVinsgFb9L5qtP8u_k5HZwCqWuI |
ContentType | Journal Article |
Contributor | Kittleson, Michelle M Dunlay, Shannon M Sandhu, Alexander T Vest, Amanda R Woo, Y Joseph Heidenreich, Paul A Gentile, Federico Dixon, Dave L Wijeysundera, Duminda N Hernandez, Adrian F Milano, Carmelo A Allen, Larry A O'Gara, Patrick T Goldberger, Zachary D Al-Khatib, Sana M Cigarroa, Joaquin E Piano, Mariann R Hayek, Salim S Nnacheta, Lorraine C Deswal, Anita Tamis-Holland, Jacqueline E Byun, Joni J Stevenson, Lynne Warner Bozkurt, Biykem Spatz, Erica S Fedson, Savitri E Khazanie, Prateeti Mark, Daniel B Aguilar, David Lee, Christopher S Colvin, Monica M Palaniappan, Latha P Beckman, Joshua A Marine, Joseph E Hlatky, Mark A Joglar, José A Haynes, Norrisa Link, Mark S Armbruster, Anastasia L Fleisher, Lee A Yancy, Clyde W Evers, Linda R Gorenek, Bulent Mukherjee, Debabrata Fang, James C Fonarow, Gregg C Drazner, Mark H Birtcher, Kim K Jones, W Schuyler Vardeny, Orly de las Fuentes, Lisa Rab, Tanveer |
Contributor_xml | – sequence: 1 givenname: Paul A surname: Heidenreich fullname: Heidenreich, Paul A – sequence: 2 givenname: Biykem surname: Bozkurt fullname: Bozkurt, Biykem – sequence: 3 givenname: David surname: Aguilar fullname: Aguilar, David – sequence: 4 givenname: Larry A surname: Allen fullname: Allen, Larry A – sequence: 5 givenname: Joni J surname: Byun fullname: Byun, Joni J – sequence: 6 givenname: Monica M surname: Colvin fullname: Colvin, Monica M – sequence: 7 givenname: Anita surname: Deswal fullname: Deswal, Anita – sequence: 8 givenname: Mark H surname: Drazner fullname: Drazner, Mark H – sequence: 9 givenname: Shannon M surname: Dunlay fullname: Dunlay, Shannon M – sequence: 10 givenname: Linda R surname: Evers fullname: Evers, Linda R – sequence: 11 givenname: James C surname: Fang fullname: Fang, James C – sequence: 12 givenname: Savitri E surname: Fedson fullname: Fedson, Savitri E – sequence: 13 givenname: Gregg C surname: Fonarow fullname: Fonarow, Gregg C – sequence: 14 givenname: Salim S surname: Hayek fullname: Hayek, Salim S – sequence: 15 givenname: Adrian F surname: Hernandez fullname: Hernandez, Adrian F – sequence: 16 givenname: Prateeti surname: Khazanie fullname: Khazanie, Prateeti – sequence: 17 givenname: Michelle M surname: Kittleson fullname: Kittleson, Michelle M – sequence: 18 givenname: Christopher S surname: Lee fullname: Lee, Christopher S – sequence: 19 givenname: Mark S surname: Link fullname: Link, Mark S – sequence: 20 givenname: Carmelo A surname: Milano fullname: Milano, Carmelo A – sequence: 21 givenname: Lorraine C surname: Nnacheta fullname: Nnacheta, Lorraine C – sequence: 22 givenname: Alexander T surname: Sandhu fullname: Sandhu, Alexander T – sequence: 23 givenname: Lynne Warner surname: Stevenson fullname: Stevenson, Lynne Warner – sequence: 24 givenname: Orly surname: Vardeny fullname: Vardeny, Orly – sequence: 25 givenname: Amanda R surname: Vest fullname: Vest, Amanda R – sequence: 26 givenname: Clyde W surname: Yancy fullname: Yancy, Clyde W – sequence: 27 givenname: Joshua A surname: Beckman fullname: Beckman, Joshua A – sequence: 28 givenname: Patrick T surname: O'Gara fullname: O'Gara, Patrick T – sequence: 29 givenname: Sana M surname: Al-Khatib fullname: Al-Khatib, Sana M – sequence: 30 givenname: Anastasia L surname: Armbruster fullname: Armbruster, Anastasia L – sequence: 31 givenname: Kim K surname: Birtcher fullname: Birtcher, Kim K – sequence: 32 givenname: Joaquin E surname: Cigarroa fullname: Cigarroa, Joaquin E – sequence: 33 givenname: Lisa surname: de las Fuentes fullname: de las Fuentes, Lisa – sequence: 34 givenname: Dave L surname: Dixon fullname: Dixon, Dave L – sequence: 35 givenname: Lee A surname: Fleisher fullname: Fleisher, Lee A – sequence: 36 givenname: Federico surname: Gentile fullname: Gentile, Federico – sequence: 37 givenname: Zachary D surname: Goldberger fullname: Goldberger, Zachary D – sequence: 38 givenname: Bulent surname: Gorenek fullname: Gorenek, Bulent – sequence: 39 givenname: Norrisa surname: Haynes fullname: Haynes, Norrisa – sequence: 40 givenname: Mark A surname: Hlatky fullname: Hlatky, Mark A – sequence: 41 givenname: José A surname: Joglar fullname: Joglar, José A – sequence: 42 givenname: W Schuyler surname: Jones fullname: Jones, W Schuyler – sequence: 43 givenname: Joseph E surname: Marine fullname: Marine, Joseph E – sequence: 44 givenname: Daniel B surname: Mark fullname: Mark, Daniel B – sequence: 45 givenname: Debabrata surname: Mukherjee fullname: Mukherjee, Debabrata – sequence: 46 givenname: Latha P surname: Palaniappan fullname: Palaniappan, Latha P – sequence: 47 givenname: Mariann R surname: Piano fullname: Piano, Mariann R – sequence: 48 givenname: Tanveer surname: Rab fullname: Rab, Tanveer – sequence: 49 givenname: Erica S surname: Spatz fullname: Spatz, Erica S – sequence: 50 givenname: Jacqueline E surname: Tamis-Holland fullname: Tamis-Holland, Jacqueline E – sequence: 51 givenname: Duminda N surname: Wijeysundera fullname: Wijeysundera, Duminda N – sequence: 52 givenname: Y Joseph surname: Woo fullname: Woo, Y Joseph |
Copyright | Copyright © 2021 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2021 Elsevier Inc. All rights reserved. |
CorporateAuthor | Writing Committee Members ACC/AHA Joint Committee Members |
CorporateAuthor_xml | – name: ACC/AHA Joint Committee Members – name: Writing Committee Members |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.cardfail.2022.02.010 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-8414 |
ExternalDocumentID | 35378257 |
Genre | Journal Article Practice Guideline |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO ABBQC ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEVXI AFCTW AFJKZ AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CGR COF CS3 CUY CVF DU5 EBS ECM EFJIC EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HX~ HZ~ IHE J1W KOM M29 M41 MO0 N9A NPM O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UHS WUQ Z5R ~G- 7X8 AAYWO ACIEU ACVFH ADCNI AEUPX AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKYEP APXCP EFKBS |
ID | FETCH-LOGICAL-p211t-c84f73c718e57a267446b40df5dcb0d58144ec5ebece2e9ca8e15b89eaf8da0d3 |
ISSN | 1532-8414 |
IngestDate | Tue Aug 05 09:48:22 EDT 2025 Thu Apr 03 07:01:07 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Copyright © 2021 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p211t-c84f73c718e57a267446b40df5dcb0d58144ec5ebece2e9ca8e15b89eaf8da0d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-2 ObjectType-Feature-3 content type line 23 |
PMID | 35378257 |
PQID | 2647212789 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2647212789 pubmed_primary_35378257 |
PublicationCentury | 2000 |
PublicationDate | 2022-May 20220501 |
PublicationDateYYYYMMDD | 2022-05-01 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-May |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of cardiac failure |
PublicationTitleAlternate | J Card Fail |
PublicationYear | 2022 |
SSID | ssj0008407 |
Score | 2.6888807 |
Snippet | The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | e1 |
SubjectTerms | American Heart Association Cardiology Heart Failure - drug therapy Heart Failure - therapy Humans Research Report United States - epidemiology |
Title | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35378257 https://www.proquest.com/docview/2647212789 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bS8MwFMeDbiC-iHfnjQi-jc6tTXp5klJWhmxTtIO9laRJQZFtaPfip_ekzboKFaYvoYStDfmlJ-e05_yL0C34rMLyGDO42WUGcYVteDahBrMhlmCcdUUu1zQa24MJeZjS6VrNIq8uyXgn-aqtK_kPVegDrqpK9g9ky5NCBxwDX2iBMLQbMTZha2z7A1-JIgQBtIPwxQfqSrpKeY-rFMJ1jkv-3B4Wd9YO2eu7VhOpcU6TfOEk7bTyK_1sAMLKMhOvNGdg70hRptmRNX3aBppuhTWtGDTZq7WzRcj_1lGjUSPpqKvn4qc6SfWHsPX4MQ4nw2Ec9afRNmqa4NGbDdT0g-fhU7ltQqTpFOK2xfAq5dz11_k9Jsh9g2gf7el5w35B6ABtydkh2hnptIUjdK_OhwHUHWC6U5BwCQkDJAyQ8BoSnqc4h4Q1pGM0CftRMDD0lyuMBQTUmZG4JHWsBPZ9SR1m2g4E3Zx0RUpFwruCuhDGyoSqG0ia0kuYK3uUu55kqSvU_XGCGrP5TJ4hTFzb5innnFBJiHA8KS0p4JinzBKO00I3q1mIwTKo1z1sJufLz9hUXwboqUrnFjotpideFBImsUUtcA2pc77Bvy_Q7nptXaJG9rGUV-CJZfxaM_wGBqgwLQ |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2022+AHA%2FACC%2FHFSA+Guideline+for+the+Management+of+Heart+Failure&rft.jtitle=Journal+of+cardiac+failure&rft.date=2022-05-01&rft.issn=1532-8414&rft.eissn=1532-8414&rft.volume=28&rft.issue=5&rft.spage=e1&rft_id=info:doi/10.1016%2Fj.cardfail.2022.02.010&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1532-8414&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1532-8414&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1532-8414&client=summon |